Antigen-presenting cell vaccine
An antigen-presenting cell vaccine, or an APC vaccine, is a vaccine made of antigens and antigen-presenting cells (APCs).
As of March 2019, the only APC vaccine approved by the American Food and Drug Administration is for prostatic acid phosphatase, a commonly over-expressed prostate cancer antigen.[1][2]
References
- O'Neill, David W. (November 2010). "Dendritic cells and T cells in immunotherapy". Journal of Drugs in Dermatology: JDD. 9 (11): 1383–1392. ISSN 1545-9616. PMID 21061761.
- MD, Marc S. Ernstoff; FACP, Igor Puzanov, MD, MSCI; PhD, Caroline Robert, MD; MD, Adi M. Diab; PhD, Peter M. Hersey, MD (2019-03-15). SITC's Guide to Managing Immunotherapy Toxicity. Springer Publishing Company. pp. xviii. ISBN 978-0-8261-7215-0.
{{cite book}}: CS1 maint: multiple names: authors list (link)
External links
- Antigen-presenting cell vaccine entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.